HTFL - HeartFlow Inc Net Sales Margin

HTFL (HeartFlow) - company brandmark

Net profit per unit of revenue demonstrates current efficiency, with the latest reading standing at -33.10. Growth is driven by FDA approval of FFRct analysis and the adoption of the company's software by clinics. The high precision of its cloud AI allows Heartflow Inc (HTFL) to maintain premium pricing power. Dominance in the 3D blood flow modeling niche and active R&D efforts ensure the technological leadership of Heartflow Inc (HTFL) in cardiology.

HeartFlow Medical (HTFL) Net Return on Sales: for the period 08/09/2025 - 11/19/2026

HeartFlow Medical (HTFL) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Fundamental company valuation:HeartFlow Corp - HTFL
Flagship merchandise of HeartFlow Corp

The global diversification of the Heartflow Inc (HTFL) AI platform across medicine and pharmacology makes revenue efficiency analysis critical for assessing business sustainability. This indicator compares operating profit to market capitalization, determining the actual net income percentage during interim reporting periods. By analyzing actual net profit margins, an investor can differentiate fundamentally undervalued assets from overheated securities, thereby minimizing the risk of capital freeze.